Real-time enrollment status for this chemotherapy-induced peripheral neuropathy clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 3:48 AM UTC
| NCT Number | NCT07365007 |
| Recruiting Status | Recruiting |
| Condition | Chemotherapy-Induced Peripheral Neuropathy |
| Phase | NA |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Michigan Rogel Cancer Center |
| Last Updated on CT.gov | June 25, 2026 (Jun 25, 2026) |
As of September 2, 2026: Clinical trial NCT07365007 is currently recruiting participants. This na study for chemotherapy-induced peripheral neuropathy is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Michigan Rogel Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07365007 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07365007 was last updated Jun 25, 2026 (June 25, 2026). HelloStudys verifies this status automatically.